Literature DB >> 23624869

Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L.

Wei-Hua Zhao1, Sheng-Qi Wu, Yang-De Zhang.   

Abstract

microRNA-124 (miR-124) plays an important role in regulating growth, invasiveness, stem-like traits, differentiation and apoptosis of glioblastoma cells. PPP1R3L, an inhibitory member of the apoptosis-stimulating protein of p53 family (IASPP), is also able to affect growth, cell cycle progression, metastasis and apoptosis of various types of cancer. To investigate the regulation of PPP1R13L expression by miR-124 and their effects on proliferation, cell cycle transition and invasion in glioblastoma cells, U251 and U373 glioblastoma cells were transfected with miR-124 mimics, its negative control (NC) or an inhibitor. We found that miR-124 was downregulated in glioblastoma tissues, and inversely regulated PPP1R13L expression in U251 and U373 glioblastoma cells. PPP1R13L was found to be a direct target of miR-124 in glioblastoma cells. Overexpression of miR-124 inhibited proliferation, G1/S transition and invasiveness in glioblastoma cells. miR-124 downregulation-mediated malignant progression of glioblastoma was partly attributed to increased PPP1R13L expression. Consequently, our findings provide a molecular basis for the role of miR-124/PPP1R13L in the progression of human glioblastoma and suggest a novel target for the treatment of glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624869     DOI: 10.3892/ijmm.2013.1365

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  24 in total

1.  MicroRNA-93 regulates collagen loss by targeting MMP3 in human nucleus pulposus cells.

Authors:  Wanli Jing; Wenxue Jiang
Journal:  Cell Prolif       Date:  2015-03-27       Impact factor: 6.831

2.  Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.

Authors:  Yajun Zhang; Hongbing Li; Jichang Han; Yijie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Downregulation of rho-associated protein kinase 1 by miR-124 in colorectal cancer.

Authors:  Zuo-Wu Xi; Shi-Yong Xin; Li-Qing Zhou; Hai-Xin Yuan; Qian Wang; Kai-Xuan Chen
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

4.  iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.

Authors:  Dong Zhao; Shanliang Zheng; Xingwen Wang; Hao Liu; Kunming Zhao; Li Li; Ying Hu
Journal:  Oncogene       Date:  2022-02-15       Impact factor: 8.756

5.  MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts.

Authors:  Daren Wang; Hui Zhang; Min Li; Maria G Frid; Amanda R Flockton; B Alexandre McKeon; Michael E Yeager; Mehdi A Fini; Nicholas W Morrell; Soni S Pullamsetti; Sivareddy Velegala; Werner Seeger; Timothy A McKinsey; Carmen C Sucharov; Kurt R Stenmark
Journal:  Circ Res       Date:  2013-10-11       Impact factor: 17.367

Review 6.  Microtubule plus-end tracking proteins in neuronal development.

Authors:  Dieudonnée van de Willige; Casper C Hoogenraad; Anna Akhmanova
Journal:  Cell Mol Life Sci       Date:  2016-03-11       Impact factor: 9.261

Review 7.  Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development.

Authors:  Rikako Sanuki; Tomonori Yamamura
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

8.  MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.

Authors:  Xiao Hong Peng; Hao Ran Huang; Juan Lu; Xiong Liu; Fei Peng Zhao; Bao Zhang; Shao Xiong Lin; Lu Wang; Huai Hong Chen; Xia Xu; Fan Wang; Xiang Ping Li
Journal:  Mol Cancer       Date:  2014-08-07       Impact factor: 27.401

9.  miR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancer.

Authors:  Lei Jiang; Tiesu Lin; Chaochao Xu; Sunkuan Hu; Yangyang Pan; Rong Jin
Journal:  J Cell Mol Med       Date:  2015-11-27       Impact factor: 5.310

Review 10.  Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors.

Authors:  Peixin Dong; Kei Ihira; Junichi Hamada; Hidemichi Watari; Takahiro Yamada; Masayoshi Hosaka; Sharon J B Hanley; Masataka Kudo; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.